News

Published on 16 Oct 2023 on Zacks via Yahoo Finance

Gritstone bio Inc. (GRTS) Upgraded to Buy: What Does It Mean for the Stock?


Article preview image

Gritstone bio Inc. (GRTS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.

The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.

NASDAQ.GRTS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript

Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript May 9, 2024 Gritstone bio, Inc...

Insider Monkey via Yahoo Finance 8 May 2024

Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects Gritstone bio Inc. (GRTS) to deliver flat earnings compared to the year-ago qu...

Zacks via Yahoo Finance 2 May 2024

Gritstone (GRTS) Plummets 58% in a Week: Here's Why

Gritstone Bio GRTS is a clinical-stage biotechnology company focused on developing vaccines targe...

Zacks via Yahoo Finance 4 Apr 2024

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher - Acorda Therapeutics...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on ...

Benzinga 2 Apr 2024

What's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?

Tuesday, Gritstone Bio Inc (NASDAQ:GRTS) released preliminary data from the ongoing, signal-seeki...

Benzinga via Yahoo Finance 2 Apr 2024

Gritstone Bio launches public stock and warrant offering

Gritstone Bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company, has announced the...

Investing.com 1 Apr 2024

Do Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?

Investors in Gritstone bio, Inc. GRTS need to pay close attention to the stock based on moves in ...

Zacks via Yahoo Finance 18 Mar 2024

Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates

Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.26 per share versus the Zacks Cons...

Zacks via Yahoo Finance 5 Mar 2024

Gritstone bio (NASDAQ:GRTS) investors are sitting on a loss of 87% if they invested three years ago

Gritstone bio, Inc. (NASDAQ:GRTS) shareholders will doubtless be very grateful to see the share p...

Simply Wall St. via Yahoo Finance 15 Jan 2024

Gritstone bio Inc. (GRTS) Upgraded to Buy: What Does It Mean for the Stock?

Gritstone bio Inc. (GRTS) could be a solid addition to your portfolio given its recent upgrade to...

Zacks via Yahoo Finance 16 Oct 2023